Company Analysis
Sign in

BioVie Inc. (BIVI)

Nasdaq: BIVI · Pharmaceutical Preparations · Carson City, NV · filing with the SEC since 2013
Full chart Alerts Compare
Grade4.6
◀ Past 3.3● Present 4.2▶ Future 5.8
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in June.
Income statement, by fiscal year, newest first
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2018FY 2018FY 2017
Period endingJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019Jun 30, 2018Jun 30, 2017
Report filedAug 13, 2026Aug 15, 2025Sep 30, 2024Aug 16, 2023Sep 27, 2022Aug 30, 2021Aug 6, 2020Sep 27, 2019Oct 5, 2018Aug 24, 2017
Research and development13,962,3609,266,73423,100,39433,299,50317,258,3412,544,648r1,150,5811,008,100370,852r466,354
Selling, general and administrative·8,570,0898,849,81411,551,5689,765,2594,637,2561,312,9301,259,0961,771,937r69,122
General and administrative8,511,0328,570,089········
Total operating expenses22,651,73318,066,20032,179,58545,080,44827,252,977138,054,1392,692,8882,496,5732,372,1661,553,614
Operating income-22,651,733-18,066,200-32,179,585-45,080,448-27,252,977-138,054,139-2,692,888-2,496,573-2,372,166-1,553,614
Interest expense17,901332,7202,893,9224,300,1502,162,989559,4554,772,42927340,960·
Interest and investment income596,771853,0291,136,703562,26444,08021,9712341,159414
Total non-operating income (expense)578,870524,08059,052-5,175,367······
Net income including non-controlling interests-22,072,863-17,542,120-32,120,533-50,255,815-26,084,468-130,249,204-16,676,768-2,444,287-2,413,122-1,330,672
Net income-22,072,863-17,542,120-32,120,533-50,255,815-26,084,468-130,249,204-16,676,768·-2,434,117-1,330,672
Net income to common shareholders··-33,006,956-50,255,815-26,084,468·····
Earnings per share, basic-3.05-12.12-73.05r-154.70rb-106.00b-1,482.00b-685.00b-98.00b··
Earnings per share, diluted-3.05-12.12-73.05r-154.70rb-106.00b-1,482.00b-685.00b-98.00b··
Earnings per share, basic and diluted·······-1.00b-3.00b-1.00b
Weighted average shares, basic7,245,9281,477,372451,853r324,835rb246,626b124,032b49,295b25,396b··
Weighted average shares, diluted7,245,9281,477,372451,853r324,835rb246,626b124,032b49,295b25,396b··
Weighted average shares, basic and diluted·······3,174,513b957,581b893,913b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-10 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
us-gaap:InterestExpenseNonoperating
Interest and investment income what its cash and investments earnedus-gaap:InterestIncomeOther
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton BIVI · research, not advice